Although the biological functions of mesothelin remain largely unknown (Bera and Pastan, 2000), there is evidence that mesothelin has the potential as a new cancer biomarker (Cheng et al, 2007) and as a target molecule for gene therapy (Chang et al, 2007). This evidence concerns the gene MSLN and cancer.